Press Resease

Global Biobanking Market - By Type Of Biobank (Disease-Oriented Biobanks And Population-Based Biobanks,), By Specimen Type (Solid Tissue, Blood Products, And Cell Lines), By Application (Research And Therapeutic), By Ownership (Non-Profit Organization, National/Regional Agencies, Private, And University), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 10-Dec-2020 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5529 Status : Published

Global Biobanking market, which accrued revenue worth 48,020 (USD Million) in 2018 and anticipated to garner earnings about 67,982 (USD Million) by 2025, is set to grow at a CAGR of nearly 4.7% during the period from 2019 to 2025.

Description

The global Biobanking market, which accrued revenue worth 48,020 (USD Million) in 2018 and anticipated to garner earnings about 67,982 (USD Million) by 2025, is set to grow at a CAGR of nearly 4.7% during the period from 2019 to 2025. The report offers valuation and analysis of the Biobanking market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, restraints, revenue estimates, avenues, current & emerging trends, and industry-validated market information. The report offers historical data from 2015 to 2018 along with a forecast from 2019 to 2025 based on value (USD Million).

Introduction

Biobanking is a method for gathering as well as preserving bio materials that are utilized for diagnosing, bio-diversity studies, and research activities. Rise in the occurrence of chronic ailments is projected to drive the market trends. With the COVID-19 pandemic, the Biobanking industry has gained massive significance globally. Moreover, the samples taken from bio banks are utilized for myriad purposes including research, drug development, clinical experiments, and therapeutics. This, in turn, has resulted in allocation of funds for government units as well as non-profit organizations to set up more such bio banks.

Market Growth Drivers

Rise in the genomic research         is anticipated to make notable contributions towards overall market earnings in the ensuing years. In addition to this, government is launching new initiatives for aiding regenerative medical research activities, thereby steering the market trends. Apparently, escalating popularity of cost-effective medicine delivery is predicted to drive the industry expansion over the forecast timeline. Breakthroughs in the regenerative medicine are set to embellish the industry size in the years ahead.  Surge in the research collaboration & alterations in the Biobanking functions are anticipated to foster the expansion of Biobanking industry in the foreseeable future.

Furthermore, massive focus on research activities pertaining to stem cell treatments along with large-scale setting up of Biobanking units across emerging economies will proliferate the expansion of the Biobanking industry over the forecast timespan. Nonetheless, growing automation costs as well as issues concerning bio-specimen sample procuring will adversely impact the expansion of Biobanking industry over the forecasting years.

North America To Make Large Contributions Towards Overall Industry Size By 2026

The expansion of the industry in the sub-continent over the forecast timeframe is due to humungous presence of hospital–based Biobanking units in the countries like the U.S. and Canada. Moreover, entry of new players in the business will further expedite the growth of the industry in the sub-continent over the estimated timespan. Apart from this, rise in the number of genome- related research activities and increase in the healthcare funding along with surge in the patient population base affected due to chronic disorders will prompt the market proceeds in the region over the assessment timeline. Escalating awareness about the bio banks in the sub-continent along with rise in the need for cost-efficient medicines like generic medicines will promulgate the business growth in North America over the anticipated timeline.

Key participants profiled in the report include Firalis S.A., CTI BIOTECH, ProMedDx LLC, ASKION GmbH, Excilone SARL, LabVantage Solutions, Inc., LGC Limited, Cureline, Inc., Hamilton Company, and PrecisionMed, Inc.

The global biobanking market is segmented as follows:

By Specimen Type

  • Blood products
  • Solid tissue
  • Cell lines
  • Others

By Application

  • Therapeutic
  • Research

By Type of Biobank

  • Population-based biobanks
  • Disease-oriented biobanks

By Ownership

  • National/regional agencies
  • Nonprofit organization
  • University
  • Private

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Biobanking Market, 2015–2025 (USD Million)
    • 2.2. Biobanking Market: Snapshot
  • Chapter 3. Global Biobanking Market– Industry Analysis
    • 3.1. Biobanking Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rise in the genomic research is anticipated to make notable contributions towards overall market earnings in the ensuing years. In addition to this, government is launching new initiatives for aiding regenerative medical research activities, thereby steering the market expansion.
      • 3.2.2. Surgical Surge in the research cullaboration & alterations in the Biobanking functions are anticipated to foster the expansion of Biobanking industry in the foreseeable future.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Specimen Type
      • 3.4.2. Market attractiveness analysis By Application
      • 3.4.3. Market attractiveness analysis By Type of Biobank
      • 3.4.4. Market attractiveness analysis By Ownership
  • Chapter 4. Global Biobanking Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biobanking Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Biobanking Market–Specimen Type Analysis
    • 5.1. Global Biobanking Market overview: By Specimen Type
      • 5.1.1. Global Biobanking Market share, By Specimen Type,2018 and 2025
    • 5.2. Blood products
      • 5.2.1. Global Biobanking Market by Blood products, 2015–2025 (USD Million)
    • 5.3. Sulid tissue
      • 5.3.1. Global Biobanking Market by Sulid tissue, 2015–2025 (USD Million)
    • 5.4. Cell lines
      • 5.4.1. Global Biobanking Market by Cell lines, 2015–2025 (USD Million)
    • 5.5. Others
      • 5.5.1. Global Biobanking Market by Others, 2015–2025 (USD Million)
  • Chapter 6. Global Biobanking Market– Application Analysis
    • 6.1. Global Biobanking Market overview: By Application
      • 6.1.1. Global Biobanking Market share, By Application , 2018 and 2025
    • 6.2. Therapeutic
      • 6.2.1. Global Biobanking Market By Therapeutic , 2015–2025 (USD Million)
    • 6.3. Research
      • 6.3.1. Global Biobanking Market By Research, 2015–2025 (USD Million)
  • Chapter 7. Global Biobanking Market– Type of Biobank Analysis
    • 7.1. Global Biobanking Market overview: By Type of Biobank
      • 7.1.1. Global Biobanking Market share, By Type of Biobank , 2018 and 2025
    • 7.2. Population-based biobanks
      • 7.2.1. Global Biobanking Market By Population-based biobanks, 2015–2025 (USD Million)
    • 7.3. Disease-oriented biobanks
      • 7.3.1. Global Biobanking Market By Disease-oriented biobanks, 2015–2025 (USD Million)
  • Chapter 8. Global Biobanking Market– Ownership Analysis
    • 8.1. Global Biobanking Market overview: By Ownership
      • 8.1.1. Global Biobanking Market share, By Ownership, 2018 and 2025
    • 8.2. National/regional agencies
      • 8.2.1. Global Biobanking Market By National/regional agencies, 2015–2025 (USD Million)
    • 8.3. Nonprofit organization
      • 8.3.1. Global Biobanking Market By Nonprofit organization, 2015–2025 (USD Million)
    • 8.4. University
      • 8.4.1. Global Biobanking Market By University, 2015–2025 (USD Million)
    • 8.5. Private
      • 8.5.1. Global Biobanking Market By Private, 2015–2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. CTI BIOTECH
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Service Portfulio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. ASKION GmbH
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Service Portfulio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Excilone SARL
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Service Portfulio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Cureline, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Service Portfulio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Development
    • 9.5. Hamilton Company
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Service Portfulio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Firalis S.A.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Service Portfulio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. LGC Limited
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Service Portfulio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. LabVantage Sulutions, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Service Portfulio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. ProMedDx LLC
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Service Portfulio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. PrecisionMed, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Service Portfulio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

Methodology


Frequently Asked Questions

Rise in the genomic research is anticipated to make notable contributions towards overall market earnings in the ensuing years. In addition to this, government is launching new initiatives for aiding regenerative medical research activities, thereby steering the market trends. Apparently, escalating popularity of cost-effective medicine delivery is predicted to drive the industry expansion over the forecast timeline. Breakthroughs in the regenerative medicine are set to embellish the industry size in the years ahead.  Surge in the research collaboration & alterations in the Biobanking functions are anticipated to foster the expansion of Biobanking industry in the foreseeable future. Furthermore, massive focus on research activities pertaining to stem cell treatments along with large-scale setting up of Biobanking units across emerging economies will proliferate the expansion of the Biobanking industry over the forecast timespan.

According to Zion market research report, the global Biobanking market, which accrued revenue worth 48,020 (USD Million) in 2018 and anticipated to garner earnings about 67,982 (USD Million) by 2025, is set to grow at a CAGR of nearly 4.7% during the period from 2019 to 2025.

North America is likely to make noteworthy contributions towards overall market revenue. The growth of the market in the region over forecast timespan can be credited to humungous presence of hospital–based Biobanking units in the countries like the U.S. and Canada. Moreover, entry of new players in the business will further expedite the growth of the industry in the sub-continent over the estimated timespan. Apart from this, rise in the number of genome- related research activities and increase in the healthcare funding along with surge in the patient population base affected due to chronic disorders will prompt the market proceeds in the region over the assessment timeline.

The key players profiled in the report include Firalis S.A., CTI BIOTECH, ProMedDx LLC, ASKION GmbH, Excilone SARL, LabVantage Solutions, Inc., LGC Limited, Cureline, Inc., Hamilton Company, and PrecisionMed, Inc.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social